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Madam, Congenital heart
diseases (CHD) are the problems
that cover the most common
type of deformity during birth.
The problems could possibly be
the accumulation of plaque in the
arteries of heart that minimize
the supply of oxygen rich blood
to the heart muscles thus
preventing it from normal
workout. Common defects are
found inside the walls and valves
of heart or the enlarged blood
vessels that carry blood towards
and from the heart. The CHD can
range from simple to much
complex and disparaging
conditions. CHD takes place in
the foetus due to the changes in
DNA mutations in particular
genes that are inherited. The
molecular mechanisms resulting
in CHD are multiplex. Several
factors can play a part in the development of CHD such as
genetic susceptibility, epigenetic mechanism and
environmental effects.1 Among these factors DNA
methylation is much known to be associated with CHD,
that take place during pregnancy.
Epigenetic modifications in the genome such as DNA
methylation have been suggested to play a role in the
processes involved in cardiovascular diseases. DNA
methylation is one of the forms of epigenetic gene
regulation.2 This process involves the incorporation of
methyl group at the C5 position of cytosine altering the
pattern of DNA producing possible changes in the gene
expression.3 DNA methylation is an epigenetic gadget
that determines whether or not a gene is expressed,
guides stem cells as they get a shape of specialized cells
from blank slates. 
The association between CHD and DNA methylation is
not understood clearly, however many studies have
shown substantial findings regarding association
between them. Several DNA methylation approaches
have been used which differ from one another
illustrating the mechanism which include global DNA
methylation, candidate gene and epigenome-wide
association studies. CHD has been reportedly linked
with Antisense non-coding RNA in the INK4 locus
(ANRIL) premotor DNA methylation.4 The differences
in DNA methylation in vascular tissues with coronary
artery disease may provide insight into the
mechanisms underlying the development of
atherosclerosis.
Since the studies are ongoing on association between
DNA methylation and their consequences in the
presentation of CHD, it is expected that the newly
developed tools like next generation sequences
techniques and further workout on demethylation
phenomenon may help us to explore new ways in
sorting out the exact epigenetics mechanism of CHD
thus helping us in the treatment of complicated heart
diseases. DNA methylation abnormalities involved in
CHD once explored may help in prediction of
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